Analytic Investors’s Pfizer PFE Stock Holding History

Analytic Investors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$43.5M	Buy	1,353,166 +1,019,046	+305%	+$34.1M	0.49%	58
2016 Q2	$11.2M	Sell	334,120 -550,415	-62%	-$17.6M	0.13%	136
2016 Q1	$24.9M	Sell	884,535 -51,865	-6%	-$1.48M	0.3%	84
2015 Q4	$28.7M	Buy	936,400 +247,354	+36%	+$7.78M	0.36%	75
2015 Q3	$20.5M	Buy	689,046 +643,730	+1,421%	+$20.6M	0.27%	88
2015 Q2	$1.44M	Sell	45,316 -424,224	-90%	-$13.8M	0.02%	318
2015 Q1	$15.5M	Buy	469,540 +383,986	+449%	+$12.2M	0.21%	115
2014 Q4	$2.53M	Sell	85,554 -467,196	-85%	-$13.4M	0.04%	231
2014 Q3	$15.5M	Sell	552,750 -1,331,287	-71%	-$37.4M	0.22%	120
2014 Q2	$53.1M	Sell	1,884,037 -604,026	-24%	-$17.2M	0.86%	39
2014 Q1	$75.8M	Sell	2,488,063 -982,447	-28%	-$29.3M	1.15%	18
2013 Q4	$101M	Sell	3,470,510 -250,923	-7%	-$7.3M	1.67%	10
2013 Q3	$101M	Buy	3,721,433 +1,695,599	+84%	+$46.1M	1.63%	10
2013 Q2	$53.8M	Buy	+2,025,834	New	+$56M	0.89%	23

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Analytic Investors's PFE Position: Q3 2016 in Review

Analytic Investors increased its Pfizer (PFE) stake by 305% in Q3 2016, buying an estimated $34.1M and bringing the position to 1,353,166 shares worth $43.5M. The position accounts for 0.49% of the portfolio, ranked #58.

Analytic Investors first reported a position in PFE in Q2 2013 and has held it in 14 quarters since. The position peaked at $101M in Q3 2013. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Analytic Investors held 1,353,166 shares of Pfizer worth $43.5M as of Q3 2016.
Analytic Investors bought 1,019,046 Pfizer shares in Q3 2016, an estimated $34.1M.
Pfizer made up 0.49% of Analytic Investors's portfolio in Q3 2016, its #58 holding.
Analytic Investors first reported a position in Pfizer in Q2 2013 and has held it in 14 quarters since.
Analytic Investors's Pfizer position peaked at $101M in Q3 2013.
1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.